POMPANO BEACH, Fla., July 17, 2007 (PRIME NEWSWIRE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare-reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced an Investor Conference call to be held on Thursday, July 26, 2007, at 4:15 PM Eastern Daylight Time. MEDirect Latino's CEO, Charles W. Hansen III, will host the call and discuss recent events at the Company including the important items disclosed to our shareholders via 8-K filings and press releases. The Company's CFO James LeGates will update our shareholders on the Company's aggressive approach on capturing efficiencies in our operation and our focus on profitability.
"Our directors have stepped up their oversight and involvement to augment our internal resources," stated Charles W. Hansen III, CEO of the Company. "We have a commitment to our shareholders, as well as the investment community, for maximum disclosure and communication. Discussion of our 8-Ks, as well as other recent significant positive corporate developments is needed at this time."
Interested parties may hear the conference call by telephone and a live web cast will be made available during and following the call at www.medirectlatino.org.
Instructions for hearing the conference call:
To hear the conference call as it takes place: -- Call 1-800-289-0544 in the United States or Canada or; -- Call 1-913-981-5533 Internationally
To hear a recording of the call live or immediately following please go to www.medirectlatino.org and click on the URL link.
About MEDirect Latino:
MEDirect Latino, Inc. (www.medirectlatino.org) is the first national provider of direct-to-consumer Medicare-reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community. MEDirect Latino is rapidly growing and uniquely positioned to service the Hispanic community in the United States and Puerto Rico. MEDirect is the only company currently positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. Type II diabetes was targeted because of its unique status within the Medicare reimbursement regime and due to its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These and other conditions represent considerable future market potential. MEDirect will scale its model by leveraging its existing client base and infrastructure in introducing new products and services to existing customers as they are identified.
The MEDirect Latino Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.